Researchmobile healthmafldwechatdigital therapeutics
WeChat Program Improves Weight Loss and Steatosis
6.1
Researchers at Xinhua Hospital in Shanghai report a 6-month randomized controlled trial (n=89) comparing a WeChat mini-program lifestyle intervention to standard care among overweight or obese adults with MAFLD. The intervention group achieved greater weight loss (60% ≥5%, 24.4% ≥10%) and improved hepatic steatosis (CAP reduction/normalization) and metabolic markers. The study suggests a scalable, low-cost approach suitable for primary care.
Key Points
- 1Demonstrates 6-month RCT with 89 MAFLD patients; 60% achieved ≥5% weight loss
- 2Shows higher CAP reduction and normalization versus control (RR 1.816, P=.01)
- 3Enables scalable, low-cost digital lifestyle management suitable for primary care and resource-limited settings
Scoring Rationale
Registered, peer-reviewed RCT shows clear benefits; single-center, small sample limits broader generalizability and long-term certainty.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
